Cited by 37Ubiquitin and proteasome pathwaysProtein Degradation and InhibitorsEnzyme Structure and Function

Structural Basis for Recruitment of DAPK1 to the KLHL20 E3 Ligase

Open access
Chen, Zhuoyao, Picaud, Sarah, Filippakopoulos, Panagis, D'Angiolella, Vincenzo, Bullock, Alex N.·2019·Structure

Published version of a preprint

Abstract

BTB-Kelch proteins form the largest subfamily of Cullin-RING E3 ligases, yet their substrate complexes are mapped and structurally characterized only for KEAP1 and KLHL3. KLHL20 is a related CUL3-dependent ubiquitin ligase linked to autophagy, cancer, and Alzheimer's disease that promotes the ubiquitination and degradation of substrates including DAPK1, PML, and ULK1. We identified an "LPDLV"-containing motif in the DAPK1 death domain that determines its recruitment and degradation by KLHL20. A 1.1-Å crystal structure of a KLHL20 Kelch domain-DAPK1 peptide complex reveals DAPK1 binding as a loose helical turn that inserts deeply into the central pocket of the Kelch domain to contact all six blades of the β propeller. Here, KLHL20 forms salt-bridge and hydrophobic interactions including tryptophan and cysteine residues ideally positioned for covalent inhibitor development. The structure highlights the diverse binding modes of β-propeller domains versus linear grooves and suggests a new target for structure-based drug design.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.str.2019.06.005

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Crystal structures of peptide substrate complexes have been reported for four BTB-Kelch family members, including KEAP1, KLHL2, KLHL3 and KLHL20.

    “Crystal structures of peptide substrate complexes have been reported for four BTB-Kelch family members, including KEAP1, KLHL2, KLHL3 and KLHL20 (refs 80,81,82 ).”

    From Targeted protein degradation: expanding the toolbox (2019) · cites this paper as [82]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chen, Z., Picaud, S., Filippakopoulos, P., D'Angiolella, V., & Bullock, A. N.
Affiliations
University of Oxford (GB)
Corresponding author
Bullock, Alex N.
Venue
Structure
Publisher
Elsevier BV
Published
2019-09
Volume
27
Issue
9
Pages
1395-1404.e4
ISSN
0969-2126 (ISSN-L)
OpenAlex
W2954075939
Cited by
37
References
43
Citations by year
2026: 4 · 2025: 9 · 2024: 6 · 2023: 3 · 2022: 5 · 2021: 2 · 2020: 6 · 2019: 2
FWCI
1.24
Type
journal article
Language
en
Open access
Locations
  • Structure (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by)
Funders
  • China Scholarship Council - Nuffield Department of Medicine Scholarship
  • Medical Research Council (MR/N010051/1, MC_UU_00001/7)
  • Cancer Research UK (C5255/A18085)
  • AbbVie
  • Bayer Pharma
  • Boehringer Ingelheim
  • Canada Foundation for Innovation
  • Eshelman Institute for Innovation
  • Genome Canada
  • Innovative Medicines Initiative (115766)
  • Janssen
  • Merck Germany
  • MSD
  • Novartis Pharma
  • Ontario Ministry of Economic Development and Innovation
  • Pfizer
  • São Paulo Research Foundation
  • Takeda
  • Wellcome (106169/ZZ14/Z)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Physical Sciences › Materials Science › Materials Chemistry › Enzyme Structure and Function
Keywords
DAPK1, Kelch domain, death domain, substrate recognition motif, protein-protein interaction, crystal structure, beta-propeller, ubiquitination, structure-based drug design, autophagy, Alzheimer's disease
MeSH terms
Protein Domains, Binding Sites, Female, Humans, Models, Molecular, Protein Binding, Protein Structure, Secondary, Crystallography, X-Ray, Adaptor Proteins, Signal Transducing, Ubiquitination, HEK293 Cells, Hydrophobic and Hydrophilic Interactions, Proteolysis, Death-Associated Protein Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review